×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Monte Rosa Therapeutics Inc. (GLUE) NASDAQ

$4.73 (0.15) (-2.98%)

Market Cap: $245.99M

As of 07/17/24 03:59 PM EDT. Market closed.

(GLUE)

Monte Rosa Therapeutics Inc. (GLUE)
NASDAQ

$4.73
(0.15) (-2.98%)

Market Cap: $245.99M

As of 07/17/24 03:59 PM EDT. Market closed.

Add to Portfolio

small molecule protein degraders are set to reshape the way by which diseases will be treated. our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. headquartered in boston with additional laboratory facilities in basel, monte rosa therapeutics is a private company launched in 2020. initially seeded by versant ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
123
Address
.
PRICE CHART FOR MONTE ROSA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.93
Previous Close
$4.87
Days Range
$4.27 - $4.99
52 week range
$2.44 - $8.84
Volume
292,505
Avg. Volume (30 days)
300,950
Market Cap
$245.99M
Dividend Yield
-
P/E
-
Shares Outstanding
50,512,019
Open
$4.93
Previous Close
$4.87
Days Range
$4.27 - $4.99
52 week range
$2.44 - $8.84
Volume
292,505
Avg. Volume (30 days)
300,950
Market Cap
$245.99M
Dividend Yield
-
P/E
-
Shares Outstanding
50,512,019
FINANCIAL STATEMENTS FOR MONTE ROSA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MONTE ROSA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Dunn EdmundPrincipal Accounting OfficerJul 05, 2024 Sale$3.831,6106,16613,944Jul 09, 2024, 04:15 PM
Dunn EdmundPrincipal Accounting OfficerJun 03, 2024 Sale$4.041,2074,87615,554Jun 05, 2024, 04:10 PM
Yang Rick10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:09 PM
Walker Paul Edward10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:08 PM
Sonsini Peter W.10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:08 PM
SANDELL SCOTT D10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:07 PM
Mathers Edward T10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:06 PM
MAKOWER JOSHUA10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:06 PM
Makhzoumi Mohamad10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:05 PM
Landsman Liza10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:04 PM
Florence Anthony A. Jr.10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:02 PM
Chang Carmen10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:02 PM
Behbahani AliDirectorJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:01 PM
BASKETT FOREST10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:00 PM
New Enterprise Associates 17, L.P.10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 05:59 PM
Bolzon Bradley J PhDDirectorJun 28, 2021 Buy$19.00157,8953,000,0052,097,938Jun 30, 2021, 05:05 PM
Versant Venture Capital VI, L.P.10% OwnerJun 28, 2021 Buy$19.00157,8953,000,0052,097,938Jun 30, 2021, 05:00 PM
Cormorant Asset Management, LPFormer 10% OwnerJun 28, 2021 Buy$19.00600,00011,400,0003,202,200Jun 30, 2021, 04:08 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Dunn EdmundPrincipal Accounting Officer07/05/20246,166
Dunn EdmundPrincipal Accounting Officer06/03/20244,876
Yang Rick10% Owner06/28/202119,950,000
Walker Paul Edward10% Owner06/28/202119,950,000
Sonsini Peter W.10% Owner06/28/202119,950,000
SANDELL SCOTT D10% Owner06/28/202119,950,000
Mathers Edward T10% Owner06/28/202119,950,000
MAKOWER JOSHUA10% Owner06/28/202119,950,000
Makhzoumi Mohamad10% Owner06/28/202119,950,000
Landsman Liza10% Owner06/28/202119,950,000
Florence Anthony A. Jr.10% Owner06/28/202119,950,000
Chang Carmen10% Owner06/28/202119,950,000
Behbahani AliDirector06/28/202119,950,000
BASKETT FOREST10% Owner06/28/202119,950,000
New Enterprise Associates 17, L.P.10% Owner06/28/202119,950,000
Bolzon Bradley J PhDDirector06/28/20213,000,005
Versant Venture Capital VI, L.P.10% Owner06/28/20213,000,005
Cormorant Asset Management, LPFormer 10% Owner06/28/202111,400,000
Load More Insider Transactions
FUNDS WITH A POSITION IN MONTE ROSA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP4,916,0950.43%No changeOther
BLACKROCK INC.2,307,0090.00038%-2.74%Other
GEODE CAPITAL MANAGEMENT, LLC735,5330.00048%6.96%Other
RENAISSANCE TECHNOLOGIES LLC122,1000.00135%16.06%Other
CHANGE IN SHARES OUTSTANDING FOR MONTE ROSA THERAPEUTICS INC
STOCK BUYBACKS FOR MONTE ROSA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
5.56%
1Q
03/31/2024
09/30/2023
20.76%
2Q
03/31/2024
06/30/2023
21.70%
3Q
03/31/2024
03/31/2023
21.90%
4Q
03/31/2024
12/31/2022
22.99%
5Q
03/31/2024
09/30/2022
28.72%
6Q
03/31/2024
06/30/2022
28.90%
7Q
03/31/2024
03/31/2022
29.10%
8Q
03/31/2024
09/30/2021
30.81%
10Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
5.56%
1Q
09/30/2023
20.76%
2Q
06/30/2023
21.70%
3Q
03/31/2023
21.90%
4Q
12/31/2022
22.99%
5Q
09/30/2022
28.72%
6Q
06/30/2022
28.90%
7Q
03/31/2022
29.10%
8Q
09/30/2021
30.81%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MONTE ROSA THERAPEUTICS INC
LOADING...